Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
Gumá M, Budt M, Sáez A, Brckalo T, Hengel H, Angulo A, López-Botet M.
Blood. 2006 May 1;107(9):3624-31. Epub 2005 Dec 29.
Similar articles
Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.
Gumá M, Angulo A, Vilches C, Gómez-Lozano N, Malats N, López-Botet M.
Blood. 2004 Dec 1;104(12):3664-71. Epub 2004 Aug 10.
Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children.
Monsiváis-Urenda A, Noyola-Cherpitel D, Hernández-Salinas A, García-Sepúlveda C, Romo N, Baranda L, López-Botet M, González-Amaro R.
Eur J Immunol. 2010 May;40(5):1418-27. doi: 10.1002/eji.200939898. Erratum in: Eur J Immunol. 2011 Jan;41(1):258.
IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function.
Sáez-Borderías A, Romo N, Magri G, Gumá M, Angulo A, López-Botet M.
J Immunol. 2009 Jan 15;182(2):829-36.
The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M, Busch LK, Salazar-Fontana LI, Bellosillo B, Morte C, García P, López-Botet M.
Eur J Immunol. 2005 Jul;35(7):2071-80. Erratum in: Eur J Immunol. 2005 Jul;35(7):2259.
UL40-mediated NK evasion during productive infection with human cytomegalovirus.
Wang EC, McSharry B, Retiere C, Tomasec P, Williams S, Borysiewicz LK, Braud VM, Wilkinson GW.
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7570-5.
Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.
Gumá M, Cabrera C, Erkizia I, Bofill M, Clotet B, Ruiz L, López-Botet M.
J Infect Dis. 2006 Jul 1;194(1):38-41. Epub 2006 May 24.
Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
Kusumi M, Yamashita T, Fujii T, Nagamatsu T, Kozuma S, Taketani Y.
J Reprod Immunol. 2006 Jun;70(1-2):33-42. Epub 2006 Feb 20.
NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus.
Muntasell A, López-Montañés M, Vera A, Heredia G, Romo N, Peñafiel J, Moraru M, Vila J, Vilches C, López-Botet M.
Eur J Immunol. 2013 Dec;43(12):3268-78. doi: 10.1002/eji.201343773. Epub 2013 Oct 9.
Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
Galandrini R, Porpora MG, Stoppacciaro A, Micucci F, Capuano C, Tassi I, Di Felice A, Benedetti-Panici P, Santoni A.
Fertil Steril. 2008 May;89(5 Suppl):1490-6. Epub 2007 Aug 13.
The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
Wada H, Matsumoto N, Maenaka K, Suzuki K, Yamamoto K.
Eur J Immunol. 2004 Jan;34(1):81-90.
Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children.
Noyola DE, Fortuny C, Muntasell A, Noguera-Julian A, Muñoz-Almagro C, Alarcón A, Juncosa T, Moraru M, Vilches C, López-Botet M.
Eur J Immunol. 2012 Dec;42(12):3256-66. doi: 10.1002/eji.201242752. Epub 2012 Oct 25.
Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.
Muntasell A, Vilches C, Angulo A, López-Botet M.
Eur J Immunol. 2013 May;43(5):1133-41. doi: 10.1002/eji.201243117. Review.
Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts.
Zeddou M, Rahmouni S, Vandamme A, Jacobs N, Frippiat F, Leonard P, Schaaf-Lafontaine N, Vaira D, Boniver J, Moutschen M.
Retrovirology. 2007 Oct 10;4:72.
IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.
Rölle A, Pollmann J, Ewen EM, Le VT, Halenius A, Hengel H, Cerwenka A.
J Clin Invest. 2014 Dec;124(12):5305-16. doi: 10.1172/JCI77440. Epub 2014 Nov 10.
NK cell-mediated lysis of autologous HCMV-infected skin fibroblasts is highly variable among NK cell clones and polyclonal NK cell lines.
Carr WH, Little AM, Mocarski E, Parham P.
Clin Immunol. 2002 Nov;105(2):126-40.
NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.
Borrego F, Kabat J, Sanni TB, Coligan JE.
J Immunol. 2002 Dec 1;169(11):6102-11.
Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.
Martínez-Rodríguez JE, Munné-Collado J, Rasal R, Cuadrado E, Roig L, Ois A, Muntasell A, Baro T, Alameda F, Roquer J, López-Botet M.
Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2653-9. doi: 10.1161/ATVBAHA.113.302163. Epub 2013 Aug 22.
The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection.
López-Botet M, Muntasell A, Vilches C.
Semin Immunol. 2014 Apr;26(2):145-51. doi: 10.1016/j.smim.2014.03.002. Epub 2014 Mar 22. Review.
Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.
Heatley SL, Pietra G, Lin J, Widjaja JM, Harpur CM, Lester S, Rossjohn J, Szer J, Schwarer A, Bradstock K, Bardy PG, Mingari MC, Moretta L, Sullivan LC, Brooks AG.
J Biol Chem. 2013 Mar 22;288(12):8679-90. doi: 10.1074/jbc.M112.409672. Epub 2013 Jan 18.
Filters: Manage Filters